Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orly Lipsitz

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Journal of Psychopathology and Clinical Science|September 29, 2025
A dimensional latent variable model approach to connecting psychopathology and neurocognition hierarchiesOrly Lipsitz, Michael Carnovale, Anthony C Ruocco
Psychiatry Research|April 9, 2026
Psychedelics as a potential treatment for borderline personality disorder: A narrative reviewErin Artna, Guneet Sandhu, Noah Chisamore, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 21, 2025
Frameworks Used to Engage Postsecondary Students in Campus Mental Health Research: A Scoping ReviewKristin Cleverley, Soha Salman, Julia Davies, et al.
CNS Spectrums|December 3, 2020
Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of ExcellenceOrly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.
Journal of Psychiatric Research|May 28, 2021
Registered clinical studies investigating psychedelic drugs for psychiatric disordersAshley N Siegel, Shakila Meshkat, Katie Benitah, et al.
Journal of Affective Disorders|December 24, 2021
The effects of antidepressant medications on antiretroviral treatment adherence in HIV-positive individuals with depressionSabine El-Halabi, Daniel H Cooper, Danielle S Cha, et al.
Neuroscience and Biobehavioral Reviews|November 26, 2020
The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future ResearchHartej Gill, Barjot Gill, Nelson B Rodrigues, et al.
Journal of Psychiatric Research|September 10, 2021
Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of ExcellenceJoshua D Di Vincenzo, Orly Lipsitz, Nelson B Rodrigues, et al.
Journal of Affective Disorders|August 18, 2020
Impact of COVID-19 pandemic on mental health in the general population: A systematic reviewJiaqi Xiong, Orly Lipsitz, Flora Nasri, et al.
Psychiatry Research|April 9, 2021
The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellenceNelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Journal of Psychopathology and Clinical Science|September 29, 2025
A dimensional latent variable model approach to connecting psychopathology and neurocognition hierarchiesOrly Lipsitz, Michael Carnovale, Anthony C Ruocco
Psychiatry Research|April 9, 2026
Psychedelics as a potential treatment for borderline personality disorder: A narrative reviewErin Artna, Guneet Sandhu, Noah Chisamore, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 21, 2025
Frameworks Used to Engage Postsecondary Students in Campus Mental Health Research: A Scoping ReviewKristin Cleverley, Soha Salman, Julia Davies, et al.
CNS Spectrums|December 3, 2020
Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of ExcellenceOrly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.
Journal of Psychiatric Research|May 28, 2021
Registered clinical studies investigating psychedelic drugs for psychiatric disordersAshley N Siegel, Shakila Meshkat, Katie Benitah, et al.
Journal of Affective Disorders|December 24, 2021
The effects of antidepressant medications on antiretroviral treatment adherence in HIV-positive individuals with depressionSabine El-Halabi, Daniel H Cooper, Danielle S Cha, et al.
Neuroscience and Biobehavioral Reviews|November 26, 2020
The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future ResearchHartej Gill, Barjot Gill, Nelson B Rodrigues, et al.
Journal of Psychiatric Research|September 10, 2021
Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of ExcellenceJoshua D Di Vincenzo, Orly Lipsitz, Nelson B Rodrigues, et al.
Journal of Affective Disorders|August 18, 2020
Impact of COVID-19 pandemic on mental health in the general population: A systematic reviewJiaqi Xiong, Orly Lipsitz, Flora Nasri, et al.
Psychiatry Research|April 9, 2021
The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellenceNelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Pageof 6